Pharmaceutical Industry Information Portal


All posts by tag


Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...

China has provided over 480 million doses of COVID-19 vaccines to world

China has provided more than 480 million doses of COVID-19 vaccines to the world, a Chinese Foreign Ministry spokesperson said here Friday.  Wang Wenbin said...

Sinopharm’s Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion doses

A Wuhan-based affiliate of China National Pharmaceutical Group (Sinopharm) said the start of operations at a new factory will raise the annual production capacity of its COVID-19 vaccine to at least 1 billion doses.

Expert Articles